Pharmaron Beijing Co., Ltd. Class H (17Q1) Stock Statistics & Valuation Metrics

Pharmaron Beijing Co., Ltd. Class H has a market cap or net worth of EUR 10.12B. The enterprise value is EUR 63.14B.

Market Cap

EUR 10.12B

Enterprise Value

EUR 63.14B

Pharmaron Beijing Co., Ltd. Class H has 359,977,870 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

359,977,870

Owned by Insiders

―

Owned by Institutions

9.88%

Pharmaron Beijing Co., Ltd. Class H’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.84%.

Return on Equity (ROE)

0.11

Return on Assets (ROA)

0.06

Return on Invested Capital (ROIC)

7.84%

Return on Capital Employed (ROCE)

0.10

Revenue Per Employee

561.83K

Profits Per Employee

66.32K

Employee Count

25,088

Asset Turnover

0.52

Inventory Turnover

6.24

The current PE Ratio of Pharmaron Beijing Co., Ltd. Class H is 44.65. Pharmaron Beijing Co., Ltd. Class H’s PEG ratio is 2.71.

PE Ratio

44.65

PS Ratio

4.08

PB Ratio

4.80

Price to FCF

-249.65

Price to Operating Cash Flow

29.88

PEG Ratio

2.71

In the last 12 months, Pharmaron Beijing Co., Ltd. Class H had revenue of 14.10B and earned 1.66B in profits. Earnings per share was 0.94.

Revenue

14.10B

Gross Profit

4.91B

Operating Income

1.93B

Pretax Income

1.91B

Net Income

1.66B

EBITDA

3.29B

Earnings Per Share (EPS)

0.94

In the last 12 months, operating cash flow was 2.75B and capital expenditures -2.99B, giving a free cash flow of -242.61M billion.

Operating Cash Flow

2.75B

Free Cash Flow

-242.61M

Free Cash Flow per Share

-0.14

Pharmaron Beijing Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of 0.75%

Dividend Per Share

―

Dividend Yield

0.75%

Payout Ratio

N/A

Free Cash Flow Yield

-0.40%

Earnings Yield

2.18%

Beta

0.78

52-Week Price Change

27.07%

50-Day Moving Average

3.21

200-Day Moving Average

2.49

Relative Strength Index (RSI)

56.71

Average Volume (3m)

1,112

Pharmaron Beijing Co., Ltd. Class H upcoming earnings date is Mar 29, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 27, 2026

Next Earnings Date

Mar 29, 2027

Ex-Dividend Date

―

Pharmaron Beijing Co., Ltd. Class H as a current ratio of 0.93, with Debt / Equity ratio of 22.68%

Current Ratio

0.93

Quick Ratio

0.75

Debt to Market Cap

0.10

Net Debt to EBITDA

0.73

Interest Coverage Ratio

10.00

In the past 12 months, Pharmaron Beijing Co., Ltd. Class H has paid 357.52M in taxes.

Income Tax

357.52M

Effective Tax Rate

0.19

Pharmaron Beijing Co., Ltd. Class H EV to EBITDA ratio is 19.37, with an EV/FCF ratio of -266.22.

EV to Sales

4.35

EV to EBITDA

19.37

EV to Free Cash Flow

-266.22

EV to Operating Cash Flow

25.66

Pharmaron Beijing Co., Ltd. Class H has EUR 4.03B in cash and marketable securities with EUR 7.46B in debt, giving a net cash position of -EUR 3.43B billion.

Cash & Marketable Securities

EUR 4.03B

Total Debt

EUR 7.46B

Net Cash

-EUR 3.43B

Net Cash Per Share

-EUR 9.53

Tangible Book Value Per Share

EUR 7.03

Gross margin is 33.20%, with operating margin of 13.75%, and net profit margin of 11.05%.

Gross Margin

33.20%

Operating Margin

13.75%

Pretax Margin

13.25%

Net Profit Margin

11.05%

EBITDA Margin

22.44%

EBIT Margin

14.30%

The average price target for Pharmaron Beijing Co., Ltd. Class H is EUR 4.72, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

EUR 4.72

Price Target Upside

39.61% Upside

Analyst Consensus

Strong Buy

Analyst Count

8

Revenue Growth Forecast

17.92%

EPS Growth Forecast

14.10%

Smart Score

6

AI Score

―